Complement activity was compared in 50 low birth weight infants divided into appropriate and small for gestational age groups; the influence of birth weight and gestational age on complement development was also investigated. CHW and kinetics (tHso) of both classical and alternative pathway activity of complement, C3, and Factor B levels were significantly higher in small for gestational age infants (classical pathway CHs, 630 HU/ml f 184 SD, C P tHs, 77 min + 47; aternative pathway CHS0, 44.8 HU/ml & 11.3; AP tHso, 56 min f 43; C3, 73.98 mg/dl f 12.68; and Factor B, 13.17 mg/dl 2 3.67) than in weight-matched appropriate for gestational age infants (CP CHW, 523 HU/ml 2 152; C P tH9, 105 min + 49; AP CHW, 38.8 HU/ml f 13; AP tHW, 90 min 2 53; C3, 58.14 mg/dl f 9.43; and Factor B, 9.32 mg/dl+ 1.73). Complement values were lower in low birth weight infants than in adult controls ( P < 0.001 in all cases). All complement parameters were mainly correlated with gestational age; CHso values of the classical and alternative pathways were also highly correlated with each other
38.8 HU/ml f 13; AP tHW, 90 min 2 53; C3, 58.14 mg/dl f 9.43; and Factor B, 9 .32 mg/dl+ 1.73). Complement values were lower in low birth weight infants than in adult controls ( P < 0.001 in all cases). All complement parameters were mainly correlated with gestational age; CHso values of the classical and alternative pathways were also highly correlated with each other (r = 0.64; P < 0.001).
Low birth weight infants, especially preterm infants, have an important defect of complement activity. Complement factors increase gradually during gestation and intrauterine growth retardation does not affect complement development. Classical and alternative complement pathway activities have a similar development pattern.
Abbreviations AGA, appropriate for gestational age AP, alternative pathway CP, classical pathway EA, antibody-sensitized sheep erythrocytes HU/ml, hemolitic unit/ml RaRBC, rabbit red blood cells SGA, small for gestational age Several studies have reported reduced activity of both CP and AP of complement in term newborn infants as compared with their mothers or adult controls (9) . Given the importance of the serum complement system in the host's defense mechanism against infection (lo), this reduction may partially explain the increased susceptibility of newborn infants to infection.
Complement activity is lower in low birth weight infants than in term infants; however, the relationship of gestational age and/ or birth weight to the level of complement activity is still controversial (1, 6, 8, 14, 16) . The purpose of the present study was to investigate the effects of birth weight and gestational age on complement development (CH50 and kinetics of both CP and AP, C3, and Factor B levels) in low birth weight infants divided into appropriate and small for gestational age groups.
PATIENTS AND METHODS
We studied 50 healthy low birth weight babies, 25 AGA and 25 SGA, according to standard growth charts (4) . AGA included 13 males and 12 females and SGA eight males and 17 females. Twelve normal term newborns (seven males and five females) were also included in the study. Gestational age was estimated by the method of Dubowitz et a]. (7) and by maternal menstrual dates. Apgar at 5 rnin was 3 8 in all infants. Infection, hemolytic disease of the newborn, respiratory distress, congenital malformation, or other serious disease precluded entry into the study. Neither infection nor prolonged rupture of the membranes were present in mothers.
Venous blood (0.5 ml), obtained within 48 h after birth (mean, 13 h), was allowed to clot and the sera were stored in liquid nitrogen until analysis. Serum samples from 35 healthy adult volunteers were stored in the same fashion. Informed consent was obtained from babies' parents.
CP activity. A modified Mayer's technique adapted for microtiter plates was used (1 1). Briefly, 60 pl of a 1 % suspension of EA in veronal buffered saline pH 7.5 were added to each well containing 180 ul of serum diluted in veronal buffered saline in order to iave a final EA concentration of 0.25% and a final serum dilution ranging from 1/160 to 11320. Four different serum concentrations were used in each assay. In order to satisfy von Krogh's equation (1 I), lower serum dilutions were employed whenever defective results were obtained with the above dilutions. After 30 rnin incubation at 37"C, the optical density was measured at 492 nm using a microELISA photometer (Titertek Multiskan Flow Laboratory) and compared with the optical density of a standard hemolysis curve obtained by mixing suitable amounts of unlysed 0.25% EA in veronal buffered saline and 0.25% EA lysed by freezing for 10 rnin in liquid nitrogen. The CHso (HU/ml) was calculated according to Mayer (1 1). The percentage of hemolysis was also measured after 0, 10, 20, 30, 45,60,90, 120, and 150 rnin of incubation and the time necessary to reach 50% hemolysis with the 11240 serum dilution, tHso, was calculated by plotting time (x) versus percentage of hemolysis (Y).
AP activity. A modified Ishizaka and Platts-Mill's technique adapted for microtiter plates was used (13) . Briefly, 60 p1 of a 2% suspension of RaRBC in veronal buffered saline containing 2 mM MgS04 and 0.01 M EGTA (pH 7.5) were added to each well containing 180 of serum diluted in the same buffer to a final concentration of RaRBC of 0.5% and to final serum concentrations ranging from 1:8 to 1: 16. Four different dilutions were used for each serum. CHSo (HU/ml) was calculated as described above for the CP. The standard hemolysis curve was prepared by mixing suitable quantities of unlysed and lysed 0.5% RaRBC. The time necessary to reach 50% hemolysis using the 1: 12 serum dilution, tHS0, was calculated by plotting time (x) versus percentage of hemolysis (y). As reported elsewhere (12) , this microtechnique assures highly accurate and reproducible results for both complement pathways.
Effect of IgG on the AP activity. The AP activity was assessed in the serum of a preterm infant (IgG levels = 860 mg/dl) before and after addition of various concentrations (100-1600 mg/dl) of human standard globulins. The serum of a term newborn (IgG levels, 1300 mg/dl) served as control.
C3 and Factor B levels determination. C3 and Factor B levels in the 50 low birth weight were determined by single radial immunodiffusion, C3 levels were assessed by employing Behring LC Partigen C3c plates (Lot. 055825). Factor B levels were assessed by employing Kallestad Endoplate Factor B test kit (Lot. P0589).
Statistical analysis. Statistical analysis was performed by calculating the mean, the standard deviation, the correlation coefficient (by the least square method) and Student's t test.
RESULTS
The data are summarized in Table 1 and 2. As for the 35 healthy adults, mean values f SD were as follows: CP, CHso = 1167 f 113 and tHso, 30 f 1; AP, CHso = 96 f 16 and tHso = 10 2 2; C3, 130 k 47; and Factor B, 18.7 f 3.2. AGA and SGA infants had comparable mean birth weights whereas mean gestational age was significantly higher in the SG.4 infants.
CP activity. In normal term newborns, activity (CHSo and tHso) was significantly lower than in adults, but significantly higher than in AGA whereas normal term newborn and SGA activity were not significantly different (Table 2 ). CP activity, as estimated by both CH50 and tH50, was significantly higher in SGA than in AGA infants (Table 1 ). All but two low birth weight infants had CP activity below the 95% confidence interval for adult controls. No sex differences were found. In the overall population of low birth weight infants no significant correlation was found between birth weight and CHso but the correlation between gestational age and both CH50 and tH50 were highly significant ( Fig. 1A and B) . The tH50 was also significantly correlated with birth weight (r = 0.29, P < 0.05).
AP activity. In the normal term newborns CHSO and tHSo activity was significantly lower than in adults but significantly higher than in AGA whereas activity of term newborn and SGA were not significantly different (Table 2 ). Only two low birth weight infants had CH5, values within the 95% confidence interval for adult controls. Mean values of CH50 and tH50 were significantly higher in SGA than in AGA infants (Table 1) . No sex differences in AP CHSO or tHS0 were found. In the overall population of low birth weight infants correlations between gestational age and both CHso and ~H S O were highly significant ( Fig. 2A and B) .
Birth weight and CH50 were also statistically correlated ( r = 0.278, P < 0.05) but the correlation coefficient was rather low.
Birth weight and tHsO were not significantly correlated. CHso values of CP and AP were highly correlated (Fig. 3) . In Figure 4 examples of the kinetic pattern of AP activation in a preterm infant (gestational age, 3 1 wk), a term infant and an adult control are presented for comparison. In vitro addition of IgG (up to 1600 mg/dl) to the serum of the preterm infant did not appreciably affect AP activity (data not shown).
C3 and Factor B levels. C3 and Factor B levels in low birth weight infants were significantly lower than in normal adult population (Table 2) . A highly significant correlation was found between gestational age and C3 (Fig. 5 ) and between gestational age and Factor B (Fig. 6) . A lower but significant correlation was found between C3 and birth weight (r = 0.289, P < 0.05) and between Factor B and birth weight (r = 0.275, P < 0.05).
DISCUSSION
Despite antibiotic therapy, infections remain a challenging problem in newborn infants. The complement system, via both the CP and the AP, plays a relevant role in host immune mechanisms. Previous studies have reported defects in the CP and AP of complement in term newborn infants as compared with adult controls (9) . In the few reports also including studies of complement in low birth weight infants, classical as well as alternative complement activity have generally been found to be lower in low birth weight than in normal term infants (1, 6, 8, 14, 16) . But it is not clear from these studies whether the defect of complement activity in low birth weight infants is the result of premature birth (6, 8) or of intrauterine growth retardation (1, 14, 16) . The purposes of the present study were to compare complement activity of both pathways in AGA and SGA low birth weight newborns, and to determine the influence of birth weight and gestational age on complement development in such infants. Infants with infection or severe illness were excluded from the study, as were those whose mothers who reported infectious diseases during pregnancy or had prolonged rupture of membranes, in order to eliminate the influence of such factors on complement activity and development. Peripheral venipuncture was performed to avoid possible contamination of cord blood with maternal blood. Our data support previous reports that CP and AP activity in newborn infants is below the normal adult range. Activity of both pathways was significantly higher in SGA than in weight-matched AGA infants. Although the CHSo and tHso of both pathways were highly correlated with gestational age, a significant positive correlation with birth weight was found only for tHso of the CP and CHso of the AP; however, the coefficients for the two latter correlations were relatively low. Previous studies have reported a significative correlation of complement activity with birth weight (1, 13, 15) but this was probably due to the effect of gestational age on birth weight. In fact Shapiro et al. (15) found no differences between AGA and SGA term infants of different birth weights but comparable gestational ages. Indeed our results also show that in infants of comparable birth weights, complement activity is significantly influenced by differences in gestational age. Furthermore, complement activity was about the same in normal term newborns and SGA. Not only CH5, and tHSo but also C3 and Factor B levels correlated better with gestational age than with birth weight. The low but still significant correlation between C3 or Factor B and birth weight and between CP tH50 or AP CH50 and birth weight seems, therefore, to be due to the influence of gestational age on birth weight. Intrauterine growth retardation, therefore, does not seem to affect the development of complement activity (6, 15). The present data on C3 and Factor B together with previous data on the age-dependent increase of other complement factors suggest that the gradual increase of both AP and CP activities results at least partially from an age-dependent increase of the single complement components levels of both pathways.
Whether this increase is due to fetal production or increasing transplacental passage remains to be established; Adinolfi's data (2, 3) suggest that fetal production plays a major role. Certainly, the defect in early complement component levels might explain the increased susceptibility to infections as a result of defective opsonization capacity. Comparison of the kinetics of AP activation in newborn and adult controls revealed no difference in the patterns, but a considerable delay in complement activation was evident in the low birth weight infants. Furthermore, in those AGA and SGA infants in whom the CH50 of the AP was undetectable, no lysis of RaRBC was observed even after 150 min. This phenomenon was present in eight AGA and three SGA infants suggesting that the defect of the AP may be severe especially in preterm infants and therefore of clinical relevance. An enhancing role of IgG (Fab)? on the AP activity has been reported in previous studies (5) and confirmed by our experience with agammoglobulinemic sera (data not shown). We, therefore, explored the possibility that the defect in AP activation in preterm infants, as compared with term infants, could be due to the lower serum IgG level; however, the in vitro addition of up to 1600 mgldl of IgG had no effect. Low levels of complement factors are probably the main determinant of the defective activity of both CP and AP in low birth weight infants.
The activities of both pathways were preferentially correlated with gestational age rather than birth weight and also significantly correlated with each other, suggesting a similar developmental pattern. In conclusion, low birth weight infants, especially preterm infants, have an important defect of complement activity. Complement factors increase gradually during gestation and intrauterine growth retardation does not affect complement development. 1 
